Yahoo
BDX Becton, Dickinson and Company
Healthcare | Medical Instruments & Supplies
Valuation
P/E Ratio
27.60
Forward P/E
11.79
PEG Ratio
1.11
Technical Timing
Z-Score:
1.18
RSI (14):
53.0
Yield & Growth
Div Yield:
2.66%
Revenue Growth:
5.20%
ROE:
0.07%
Balance Sheet
Debt/Equity:
71.60
Current Ratio:
0.94
đź“° News
Yahoo
Yahoo
Yahoo
Yahoo
Yahoo
Yahoo
Yahoo
Benzinga
Yahoo
Yahoo
SeekingAlpha
SeekingAlpha
Yahoo
Yahoo
Yahoo
Yahoo
Yahoo
Benzinga
Yahoo
Yahoo
Yahoo
Yahoo
Yahoo
Yahoo
Yahoo
Yahoo
Yahoo
Benzinga
Yahoo
Yahoo
CNBC
CNBC
Yahoo
Yahoo
SeekingAlpha
Yahoo
Yahoo
Yahoo
Yahoo
Yahoo
CNBC
Yahoo
Yahoo
Yahoo
ChartMill
ChartMill
BDX |
Avantor® Announces Gerard (Jerry) Porreca as Executive Vice President, Quality and Regulatory
Yahoo
Yahoo
Yahoo
Yahoo
Benzinga
Yahoo
Yahoo
SeekingAlpha
Finnhub
Yahoo
SeekingAlpha
Benzinga
Yahoo
BDX |
Jim Cramer on Becton, Dickinson: “The Company Showed Excellent Execution Across the Board”
Yahoo
Yahoo
Yahoo
Benzinga
Yahoo
Yahoo
ChartMill
Yahoo
Yahoo
ChartMill
Yahoo
Benzinga
Yahoo
Yahoo
Yahoo
Finnhub
Yahoo
BDX |
BDX (Becton Dickinson) Posts EPS Beat in Q2 2026, Pre-Market Rallies Despite Slight Revenue Miss
ChartMill
Yahoo
SeekingAlpha
Yahoo
Yahoo
Yahoo
Finnhub
Finnhub
SeekingAlpha
SeekingAlpha
BDX |
Becton, Dickinson and Company Appoints Vitor Roque as Chief Financial Officer, Effective May 7, 2026
Finnhub
Finnhub
Finnhub
Finnhub
Finnhub
Finnhub
BDX |
Becton Dickinson Raises FY2026 Adj EPS Guidance from $12.35-$12.65 to $12.52-$12.72 vs $12.48 Est
Benzinga
Benzinga
Yahoo
CNBC
Yahoo
Yahoo
Yahoo
Yahoo
Yahoo
Yahoo
Benzinga
SeekingAlpha
Yahoo
Benzinga
Yahoo
Yahoo
Yahoo
Yahoo
Finnhub
Yahoo
Yahoo
Yahoo
Yahoo
Yahoo
BDX |
Assessing Becton Dickinson’s Valuation After Recent Share Weakness And Planned Business Separation
Yahoo
CNBC
Finnhub